Role of immunostimulatory molecules in poultry vaccines

Recent Patents on Biotechnology

Volumn 4, Issue 3, 2010, Pages 235-241

  Kumar, Sachin ^a   Koul, Monika ^b   Rai, Anant ^c  

^a VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

^b Jawaharlal Nehru Krishi Vishwa Vidyalaya   (India)

^c INDIAN VETERINARY RESEARCH INSTITUTE   (India)

Author keywords

Adjuvant; Avian cytokines; Immunostimulant; Vaccine

Indexed keywords

BIRDS; DISEASES; IMMUNE SYSTEM;

ADJUVANT; AVIAN CYTOKINE; CYTOKINE GENES; CYTOKINES; FIELD CONDITIONS; IMMUNE RESPONSE; IMMUNOSTIMULANTS; INFECTIOUS DISEASE; INNATE IMMUNE SYSTEMS; POULTRY VACCINES;

VACCINES;

BACTERIAL VACCINE; CYTOKINE; DNA VACCINE; INTERLEUKIN 12; POLYPEPTIDE; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 15; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; VIRUS VACCINE; VIRUS VECTOR;

ARTICLE; AVIAN INFLUENZA; CYTOKINE RESPONSE; DRUG EFFECT; DRUG POTENCY; IMMUNOMODULATION; IMMUNOSTIMULATION; NEGATIVE FEEDBACK; NONHUMAN; POSITIVE FEEDBACK; POULTRY FARMING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE ACTIVATION; VACCINATION; VACCINE PRODUCTION;

AVES; MAMMALIA;

EID: 78649987728     PISSN: 18722083     EISSN: None     Source Type: Journal    
DOI: 10.2174/187220810793611473     Document Type: Article

References (59)

1. Angulo FJ, Baker NL, Olsen SJ, Anderson A, Barrett TJ. Anti microbial use in agriculture: controlling the transfer of antimic robial resistance to humans. Semin Pediatr Infect Dis 2004; 15(2): 78-85.
2. Asif M, Jenkins KA, Hilton LS, Kimpton WG, Bean AG, Lowenthal JW. Cytokines as adjuvants for avian vaccines. Immunol Cell Biol 2004; 82(6): 638-643.
3. Hilton LS, Bean AG, Lowenthal JW. The emerging role of avian cytokines as immunotherapeutics and vaccine adjuvants. Vet Immunol Immunopathol 2002; 85(3-4): 119-128.
4. Allen PC, Danforth HD, Augustine PC. Dietary modulation of avian coccidiosis. Int J Parasitol 1998; 28(7): 1131-1140.
5. Jack RW, Tagg JR, Ray B. Bacteriocins of gram-positive bacteria. Microbiol Rev 1995; 59(2): 171-200.
6. Register, M.K. Poultry and livestock feed additive. US6682762 (2004).
7. Waldmann TA. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat Rev Immunol 2006; 6(8): 595-601.
8. Toro H, van Santen VL, Hoerr FJ, Breedlove C. Effects of chicken anemia virus and infectious bursal disease virus in commercial chickens. Avian Dis 2009; 53(1): 94-102.
9. Toro H, van Santen VL, Li L, Lockaby SB, van Santen E, Hoerr FJ. Epidemiological and experimental evidence for immunodeficiency affecting avian infectious bronchitis. Avian Pathol 2006; 35(6): 455-464.
10. Gupta RK. Aluminum compounds as vaccine adjuvants. Adv Drug Deliv Rev 1998; 32(3): 155-172.
11. Coley WB. The Influence of Injury upon the development of Sarcoma. Ann Surg 1898; (3): 259-284.
12. McKee AS, Munks MW, Marrack P. How do adjuvants work? Important considerations for new generation adjuvants. Immunity 2007; 27(5): 687-690.
13. Malherbe L, Mark L, Fazilleau N, McHeyzer-Williams LJ, McHeyzer-Williams MG. Vaccine adjuvants alter TCR-based selection thresholds. Immunity 2008; 28(5): 698-709.
14. Lowenthal JW, Lambrecht B, van den Berg TP, Andrew ME, Strom AD, Bean AG. Avian cytokines - the natural approach to therapeutics. Dev Comp Immunol 2000; 24(2-3): 355-365.
15. Staeheli P, Puehler F, Schneider K, Gobel TW, Kaspers B. Cytokines of birds: conserved functions-a largely different look. J Interferon Cytokine Res 2001; 21(12): 993-1010.
16. Lowenthal, J.W., Boyle, D., Bernard, Q.P. Uses of cytokines. WO2002AU0000800 (2002).
17. Darnell JE, Jr. STATs and gene regulation. Science 1997; 277(5332): 1630-1635.
18. Inagaki-Ohara K, Hanada T, Yoshimura A. Negative regulation of cytokine signaling and inflammatory diseases. Curr Opin Pharmacol 2003; 3(4): 435-442.
19. Hanada T, Yoshimura A. Regulation of cytokine signaling and inflammation. Cytokine Growth Factor Rev 2002; 13(4-5): 413-421.
20. Turpeinen T, Nieminen R, Moilanen E, Korhonen R. MAP-kinase phosphatase-1 negatively regulates the expression of interleukin-6, interleukin-8 and cyclooxygenase-2 in A549 human lung epithelial cells. J Pharmacol Exp Ther 2010; 333(1): 310-38.
21. Kutzler MA, Robinson TM, Chattergoon MA, Choo DK, Choo AY, Choe PY, et al. Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help. J Immunol 2005; 175(1): 112-123.
22. Kumar S, Ahi YS, Salunkhe SS, Koul M, Tiwari AK, Gupta PK, et al. Effective protection by high efficiency bicistronic DNA vaccine against infectious bursal disease virus expressing VP2 protein and chicken IL-2. Vaccine 2009; 27(6): 864-869.
23. Orson FM, Kinsey BM, Densmore CL, Nguyen T, Wu Y, Mbawuike IN, et al. Protection against influenza infection by cytokine-enhanced aerosol genetic immunization. J Gene Med 2006; 8(4): 488-497.
24. Li J, Liang X, Huang Y, Meng S, Xie R, Deng R, et al. Enhancement of the immunogenicity of DNA vaccine against infectious bursal disease virus by co-delivery with plasmid encoding chicken interleukin 2. Virology 2004; 329(1): 89-100.
25. Vasilakos JP, Smith RM, Gibson SJ, Lindh JM, Pederson LK, Reiter MJ, et al. Adjuvant activities of immune response modifier R-848: comparison with CpG ODN. Cell Immunol 2000; 204(1): 64-74.
26. Ben-Yehuda A, Joseph A, Barenholz Y, Zeira E, Even-Chen S, Louria-Hayon I, et al. Immunogenicity and safety of a novel IL-2-supplemented liposomal influenza vaccine (INFLUSOME-VAC) in nursing-home residents. Vaccine 2003; 21(23): 3169-3178.
27. Bukreyev A, Skiadopoulos MH, McAuliffe J, Murphy BR, Collins PL, Schmidt AC. More antibody with less antigen: can immunogenicity of attenuated live virus vaccines be improved? Proc Natl Acad Sci USA 2002; 99(26): 16987-16991.
28. Tang M, Wang H, Zhou S, Tian G. Enhancement of the immunogenicity of an infectious bronchitis virus DNA vaccine by a bicistronic plasmid encoding nucleocapsid protein and interleukin-2. J Virol Methods 2008; 149(1): 42-48.
29. Poon LL, Leung YH, Nicholls JM, Perera PY, Lichy JH, Yamamoto M, et al. Vaccinia virus-based multivalent H5N1 avian influenza vaccines adjuvanted with IL-15 confer sterile cross-clade protection in mice. J Immunol 2009; 182(5): 3063-3071.
30. Schijns VE, Weining KC, Nuijten P, Rijke EO, Staeheli P. Immunoadjuvant activities of E. coli- and plasmid-expressed recombinant chicken IFN-alpha/beta, IFN-gamma and IL-1beta in 1-day- and 3-week-old chickens. Vaccine 2000; 18(20): 2147-2154.
31. Dilaveris D, Chen C, Kaiser P, Russell PH. The safety and immunogenicity of an in ovo vaccine against Newcastle disease virus differ between two lines of chicken. Vaccine 2007; 25(19): 3792-3799.
32. Djeraba A, Musset E, Lowenthal JW, Boyle DB, Chausse AM, Peloille M, et al. Protective effect of avian myelomonocytic growth factor in infection with Marek's disease virus. J Virol 2002; 76(3): 1062-1070.
33. Fredericksen, T.L., Thaxton, J.P. Method of treating birds. EP1990000908821/5028421 (1991).
34. Sundick, R.S., Jones, L.A., Smith, D.I. Chicken interleukin-15 and uses thereof. US1996000729004 (2001).
35. Degen, W. J., Schijns, V.C. Avian cytokines, such as IL-12, comprising a p40 and/or p35 subunit and vaccines. US7347996 (2008).
36. Schultz U, Kaspers B, Staeheli P. The interferon system of non-mammalian vertebrates. Dev Comp Immunol 2004; 28(5): 499-508.
37. Lowenthal, J. W., Johnson, M.A., O'Neil, T. E., York, J.J. Uses of avian interferon gamma (IFN-y). US6642032 (2003).
38. Lowenthal, J.W., York, J.J., O'Neil, T.E., Rhodes, S., Digby, M. Recombinant avian interferon-gamma (IFN-y). US6083724. (2000).
39. Sekellick, M. J. Marcus, P. I. Ferrandino, F. A. Recombinant avian type i interferon. US6020465 (2000).
40. Kaiser P, Poh TY, Rothwell L, Avery S, Balu S, Pathania US, et al. A genomic analysis of chicken cytokines and chemokines. J Interferon Cytokine Res 2005; 25(8): 467-484.
41. Mahmood MS, Siddique M, Hussain I, Khan A, Mansoor MK. Protection capability of recombinant plasmid DNA vaccine containing VP2 gene of very virulent infectious bursal disease virus in chickens adjuvanted with CpG oligodeoxynucleotide. Vaccine 2006; 24(22): 4838-4846.
42. Taghavi A, Allan B, Mutwiri G, Van Kessel A, Willson P, Babiuk L, et al. Protection of neonatal broiler chicks against Salmonella Typhimurium septicemia by DNA containing CpG motifs. Avian Dis 2008; 52(3): 398-406.
43. Dalloul RA, Lillehoj HS, Okamura M, Xie H, Min W, Ding X, et al. In vivo effects of CpG oligodeoxynucleotide on Eimeria infection in chickens. Avian Dis 2004; 48(4): 783-790.
44. Dar A, Potter A, Tikoo S, Gerdts V, Lai K, Babiuk LA, et al. CpG oligodeoxynucleotides activate innate immune response that suppresses infectious bronchitis virus replication in chicken embryos. Avian Dis 2009; 53(2): 261-267.
45. Davis, H. L., Schorr, J., Krieg, A.M. Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant. US6406705 (2002).
46. Dalloul RA, Lillehoj HS. Recent advances in immunomodulation and vaccination strategies against coccidiosis. Avian Dis 2005; 49(1): 1-8.
47. Higuchi M, Matsuo A, Shingai M, Shida K, Ishii A, Funami K, et al. Combinational recognition of bacterial lipoproteins and peptidoglycan by chicken Toll-like receptor 2 subfamily. Dev Comp Immunol 2008; 32(2): 147-155.
48. Jenkins KA, Bean AG, Lowenthal JW. Avian genomics and the innate immune response to viruses. Cytogenet Genome Res 2007; 117(1-4): 207-212.
49. Ioannou XP, Gomis SM, Karvonen B, Hecker R, Babiuk LA, van Drunen Littel-van den Hurk S. CpG-containing oligodeoxy-nucleotides, in combination with conventional adjuvants, enhance the magnitude and change the bias of the immune responses to a herpesvirus glycoprotein. Vaccine 2002; 21(1-2): 127-137.
50. Chen M, Griffith BP, Lucia HL, Hsiung GD. Efficacy of S26308 against guinea pig cytomegalovirus infection. Antimicrob Agents Chemother 1988; 32(5): 678-683.
51. Elkins KL, Rhinehart-Jones TR, Stibitz S, Conover JS, Klinman DM. Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria. J Immunol 1999; 162(4): 2291-2298.
52. Weeratna RD, McCluskie MJ, Xu Y, Davis HL. CpG DNA induces stronger immune responses with less toxicity than other adjuvants. Vaccine 2000; 18(17): 1755-1762.
53. Stanley MA. Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential. Clin Exp Dermatol 2002; 27(7): 571-577.
54. Chen L, Ran MJ, Shan XX, Cao M, Cao P, Yang XM, et al. BAFF enhances B-cell-mediated immune response and vaccine-protection against a very virulent IBDV in chickens. Vaccine 2009; 27(9): 1393-1399.
55. Hghihghi HR, Read LR, Mohammadi H, Pei Y, Ursprung C, Nagy E, et al. Characterization of host responses against a recombinant fowlpox virus-vectored vaccine expressing the hemagglutinin antigen of an avian influenza virus. Clin Vaccine Immunol 2010; 17(3): 454-483.
56. Cochran, M.D., Wild, M.A., Winslow, B.J. Recombinant chimeric virus and uses thereof. US6183753 (1997).
57. Chieko, Kai., Kato, A. Process for preparation of cytokines using Sendai virus expression system. US6514728 (2003).
58. Yang G, Li J, Zhang X, Zhao Q, Liu Q, Gong P. Eimeria tenella: construction of a recombinant fowlpox virus expressing rhomboid gene and its protective efficacy against homologous infection. Exp Parasitol 2008; 119(1): 30-36.
59. Gerber, J.D. Adjuvant composition for mucosal and injection delivered vaccines. US6676958 (2004).